ZEC Zcash Price Prediction: 22nd of October
1 extracted signal · 0 resolved · 1 still active
C-Zar Gets Crypto Independent analyst profile- Source published
- 22 Oct 2026, 14:13 UTC
- Recorded by Tahlil Plus
- 22 Oct 2026, 16:20 UTC
AI-generated source summary
The analysis focuses on ZECUSDT, currently trading around $1245.00. The daily chart shows a significant uptrend from August, with a recent consolidation phase. On the 4-hour chart, a potential inverse head and shoulders pattern is observed, suggesting a bullish continuation. The speaker highlights a breakout from a descending trendline on the 4-hour chart, supported by increasing volume. Key support levels are identified around $1115 and $1047. The predicted target price is $1600, with a potential extension towards $2000-$2300 in the medium term. The fail bound for a bullish continuation is set below $1000, specifically around $975, invalidating the immediate upward momentum and suggesting a deeper correction. The speaker also notes that the RSI on the 4-hour chart is not overbought and the MACD is showing bullish momentum, supporting the upward outlook. The 1-hour chart shows recent price action consolidating above a key Fibonacci level, indicating potential for an upward move.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- Live evaluation in progress
1 signal remains active.
C-Zar Gets Crypto
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.